The FDA has asked Abbott Laboratories to issue a recall of the weight loss drug Meridia and to stop marketing the product in the United States due to results of a study indicating an increased risk of heart attack and stroke in Meridia users. In November 2009, the finding of a study known as SCOUT (Sibutramine Cardiovascular Outcomes Trial) prompted a Meridia recall in Europe and a FDA safety review in the United States. The study showed a 16% increase in the risk of heart attack, stroke, death and the need for resuscitation upon cardiac arrest in patients taking Meridia compared with those receiving placebo. The study also only showed a 2.5% difference in body weight between the two groups. After examining the drug’s risk-to-benefit ratio, the FDA asked Abbot Laboratories to issue a voluntary Meridia recall.
Meridia Weight Loss Drug Recall
October 19, 2010 By Leave a Comment
Speak Your Mind
You must be logged in to post a comment.